Work

First-in-human phase I trial of NHS-IL12 in advanced solid tumors.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.tps2617

Authors: Joseph W. Kim, Christopher Ryan Heery, Marijo Bilusic, Nishith K. Singh, Ravi A. Madan, Helen Sabzevari, Jeffrey Schlom, James L. Gulley

Institutions: National Institutes of Health, National Cancer Institute, EMD Serono, Inc. (United States), Merck Healthcare KGaA, Darmstadt (Germany)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600060591

Cites:

Cited by: 11

Related to: 10